SHAREHOLDERS’ EQUITY |
6 Months Ended | 9 Months Ended | 12 Months Ended | |||
|---|---|---|---|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2026 |
Dec. 31, 2025 |
Sep. 30, 2025 |
|||
| Subsidiary or Equity Method Investee [Line Items] | ||||||
| SHAREHOLDERS’ EQUITY | NOTE 7 — SHAREHOLDERS’ EQUITY
Preferred Shares — The Company is authorized to issue shares of preferred shares with a par value of $ per share with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. As of June 30, 2026 and December 31, 2025, there were preferred shares issued or outstanding.
Ordinary Shares — The Company is authorized to issue ordinary shares with a par value of $ per share. Holders of ordinary shares are entitled to one vote for each share.
In June 2025, the Company effected a 4-for-3 forward split of the outstanding shares. All share amounts have been retroactively adjusted. On October 23, 2025, in connection with the IPO, the Company issued Public Shares, which are classified as ordinary shares subject to possible redemption and are presented as temporary equity (see Notes 2 and 3)
Up to Founder Shares were subject to forfeiture to the extent the underwriters’ over-allotment option was not exercised, in order for the Founder Shares to equal 25% of the Company’s issued and outstanding ordinary shares after the IPO (excluding Private Placement Shares and EBC Founder Shares). The underwriters did not exercise the over-allotment option and delivered an over-allotment termination letter on October 27, 2025; accordingly, Founder Shares were forfeited as of December 31, 2025.
As of June 30, 2026 and December 31, 2025, there were ordinary shares issued and outstanding (excluding the Public Shares classified as temporary equity described above).
Rights — Except in cases where the Company is not the surviving company in a business combination, each holder of a right is entitled to receive one-tenth (1/10) of one ordinary share upon consummation of the Company’s initial business combination. Rights will only convert into a whole number of ordinary shares; accordingly, holders must have ten (10) Rights to receive one (1) ordinary share.
The Company does not issue fractional shares in connection with the conversion of Rights. Any fractional shares that would otherwise be issuable will be rounded down to the nearest whole share (or otherwise addressed in accordance with the applicable provisions of Cayman law).
In the event the Company is not the surviving company upon completion of the initial business combination, each holder of a Right is required to affirmatively convert such Right in order to receive the one-tenth (1/10) of one ordinary share underlying each Right upon consummation of the business combination. If the Company does not complete an initial business combination within the required time period and the Company redeems the Public Shares for the funds held in the Trust Account, holders of Rights are not entitled to any redemption proceeds with respect to such Rights, and the Rights will expire worthless.
Other — Transaction Costs Paid on Behalf of the Company
Pursuant to the Business Combination Agreement, the target paid transaction-related expenses on the Company’s behalf totaling $357,009 and $451,009 during the three and six months ended June 30, 2026, respectively. Because the Company has no obligation to repay these amounts, they were recorded as capital contributions with an offset to additional paid-in capital.
|
NOTE 7 — SHAREHOLDERS’ EQUITY
Preferred Shares — The Company is authorized to issue shares of preferred shares with a par value of $ per share with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. As of December 31, 2025, and 2024, there were preferred shares issued or outstanding.
Ordinary Shares — The Company is authorized to issue ordinary shares with a par value of $ per share. Holders of ordinary shares are entitled to one vote for each share.
In June 2025, the Company effected a 4-for-3 forward split of the outstanding shares. All share amounts have been retroactively adjusted. On October 23, 2025, in connection with the IPO, the Company issued Public Shares, which are classified as ordinary shares subject to possible redemption and are presented as temporary equity (see Notes 2 and 3)
An aggregate of up to Founder Shares were subject to forfeiture to the extent that the underwriters’ over-allotment option was not exercised, in order for the Founder Shares to equal 25% of the Company’s issued and outstanding ordinary shares after the IPO (excluding private shares and EBC Founder Shares). The underwriters did not exercise the over-allotment option and delivered an over-allotment termination letter on October 27, 2025; accordingly, Founder Shares were forfeited as of December 31, 2025. As of December 31, 2025, there were ordinary shares issued and outstanding (excluding the Public Shares classified as temporary equity described above).
Rights — Except in cases where the Company is not the surviving company in a business combination, each holder of a right is entitled to receive one-tenth (1/10) of one ordinary share upon consummation of the Company’s initial business combination. Rights will only convert into a whole number of ordinary shares; accordingly, holders must have ten (10) Rights to receive one (1) ordinary share.
The Company does not issue fractional shares in connection with the conversion of Rights. Any fractional shares that would otherwise be issuable will be rounded down to the nearest whole share (or otherwise addressed in accordance with the applicable provisions of Cayman law).
In the event the Company is not the surviving company upon completion of the initial business combination, each holder of a Right is required to affirmatively convert such Right in order to receive the one-tenth (1/10) of one ordinary share underlying each Right upon consummation of the business combination. If the Company does not complete an initial business combination within the required time period and the Company redeems the Public Shares for the funds held in the Trust Account, holders of Rights are not entitled to any redemption proceeds with respect to such Rights, and the Rights will expire worthless.
|
||||
| Goodvision Inc [Member] | ||||||
| Subsidiary or Equity Method Investee [Line Items] | ||||||
| SHAREHOLDERS’ EQUITY | Note 9. Shareholders’ Equity and Recapitalization
Goodvision Inc., a California corporation (“Goodvision California”), was incorporated under the laws of the State of California on October 2, 2019. Prior to the reorganization described below, Goodvision California had shares of no-par-value common stock issued and outstanding, all held by its founders.
Reorganization and Recapitalization
Subsequent to September 30, 2025, the group undertook a corporate reorganization and recapitalization in contemplation of a proposed de-SPAC business combination with Calisa Acquisition Corp., as described in Note 1. Management evaluated the accounting treatment of the reorganization in accordance with ASC 805, Business Combinations, and concluded that the reorganization constitutes a reverse recapitalization, with Goodvision California as the accounting predecessor. No goodwill or other intangible assets were recognized. Accordingly, the equity section of the condensed consolidated balance sheets for all periods presented has been retroactively recast to reflect the capital structure of Goodvision Cayman as if the reorganization had occurred at the earliest period presented.
Accounting Treatment
Because the reorganization was accounted for as a reverse recapitalization, the historical condensed consolidated financial statements represent a continuation of the financial statements of Goodvision California, the accounting predecessor, with the legal capital structure retroactively adjusted to reflect that of Goodvision Cayman, the legal parent. For periods prior to the issuance of Goodvision Cayman’s ordinary shares, the condensed consolidated balance sheets present ordinary share capital as ordinary shares at $ per share, or $, with a corresponding offset of $(50,000) recorded in additional paid-in capital, such that there is no net change to total shareholders’ equity (deficit) as a result of the recapitalization. Upon the issuance of the ordinary shares by Goodvision Cayman, the $(50,000) offset in additional paid-in capital was reversed and a stock subscription receivable of $() was recorded as a contra-equity item. Weighted-average ordinary shares outstanding have been retroactively restated to shares for all periods presented, and net income (loss) per ordinary share has been recomputed accordingly.
Stock Subscription Receivable
As of June 30, 2026, the Company recorded a stock subscription receivable of $50,000 related to ordinary shares issued by Goodvision Cayman at $ per share for which the proceeds had not yet been received. The subscription receivable is presented as a contra-equity item in the condensed consolidated balance sheets.
|
The Company was incorporated under the laws of the State of California on October 2, 2019.
As of September 30, 2025 and 2024, the Company had shares of no-par-value common stock issued and outstanding. All issued and outstanding shares were held by the Company’s founders. No additional paid-in capital had been recorded as of either date. |
||||